Peter Jerntorp

1.1k total citations
31 papers, 924 citations indexed

About

Peter Jerntorp is a scholar working on Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Peter Jerntorp has authored 31 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Pathology and Forensic Medicine and 7 papers in Physiology. Recurrent topics in Peter Jerntorp's work include Diabetes Management and Research (7 papers), Alcohol Consumption and Health Effects (7 papers) and Diabetes Treatment and Management (4 papers). Peter Jerntorp is often cited by papers focused on Diabetes Management and Research (7 papers), Alcohol Consumption and Health Effects (7 papers) and Diabetes Treatment and Management (4 papers). Peter Jerntorp collaborates with scholars based in Sweden and United States. Peter Jerntorp's co-authors include G. Sundkvist, G Berglund, Jan‐Olof Jeppsson, Hillevi Englund, Hans Öhlin, Lars‐Olof Almér, Sölve Elmståhl, B. Bergström, Lars Stavenow and Hélène Pessah-Rasmussen and has published in prestigious journals such as Diabetes Care, Diabetes and Stroke.

In The Last Decade

Peter Jerntorp

29 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Jerntorp Sweden 12 368 163 150 150 141 31 924
Udaya M. Kabadi United States 19 789 2.1× 219 1.3× 214 1.4× 174 1.2× 87 0.6× 112 1.2k
Frederick Wolff United States 18 360 1.0× 190 1.2× 180 1.2× 271 1.8× 207 1.5× 56 997
Outi Heikkilä Finland 15 568 1.5× 119 0.7× 132 0.9× 251 1.7× 248 1.8× 20 1.1k
H. J. G. Bilo Netherlands 18 401 1.1× 197 1.2× 136 0.9× 164 1.1× 215 1.5× 43 991
Celanie K. Christensen United States 8 547 1.5× 148 0.9× 131 0.9× 132 0.9× 398 2.8× 13 1.5k
F. A. Gries Germany 21 385 1.0× 356 2.2× 208 1.4× 340 2.3× 273 1.9× 55 1.3k
Emile E. Werk United States 21 643 1.7× 200 1.2× 184 1.2× 203 1.4× 88 0.6× 39 1.4k
Meyer D. Lifschitz United States 22 164 0.4× 143 0.9× 344 2.3× 215 1.4× 250 1.8× 74 1.6k
JR Attali France 21 349 0.9× 199 1.2× 128 0.9× 290 1.9× 447 3.2× 48 1.2k
J. A. Weaver United Kingdom 20 644 1.8× 147 0.9× 134 0.9× 218 1.5× 175 1.2× 45 1.1k

Countries citing papers authored by Peter Jerntorp

Since Specialization
Citations

This map shows the geographic impact of Peter Jerntorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Jerntorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Jerntorp more than expected).

Fields of papers citing papers by Peter Jerntorp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Jerntorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Jerntorp. The network helps show where Peter Jerntorp may publish in the future.

Co-authorship network of co-authors of Peter Jerntorp

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Jerntorp. A scholar is included among the top collaborators of Peter Jerntorp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Jerntorp. Peter Jerntorp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jeppsson, Jan‐Olof, et al.. (1996). Capillary Blood on Filter Paper for Determination of HbA1c by Ion Exchange Chromatography. Diabetes Care. 19(2). 142–145. 58 indexed citations
2.
Elmståhl, Sölve, et al.. (1995). Precipitating and Predisposing Factors of Acute Confusional State Among Emergency Department Patients. International Psychogeriatrics. 7(4). 519–526. 9 indexed citations
3.
Elmståhl, Sölve, et al.. (1992). 80-year-old men have elevated plasma concentrations of catecholamines but decreased plasma renin activity and aldosterone as compared to young men. Aging Clinical and Experimental Research. 4(4). 341–345. 6 indexed citations
4.
Elmståhl, Sölve, et al.. (1991). Body composition and dietary habits in 80-year-old smoking men without cardiovascular disease. Aging Clinical and Experimental Research. 3(3). 269–277. 6 indexed citations
5.
Öhlin, Hans, Lars Brattström, Bo Israelsson, D. BERGQVIST, & Peter Jerntorp. (1991). Atherosclerosis and acetaldehyde metabolism in blood. Biochemical Medicine and Metabolic Biology. 46(3). 317–328.
6.
7.
Brattström, Lars, Lars Stavenow, Peter Nilsson‐Ehle, et al.. (1990). Pyridoxine reduces cholesterol and low-density lipoprotein and increases antithrombin III activity in 80-year-old men with low plasma pyridoxal 5-phosphate. Scandinavian Journal of Clinical and Laboratory Investigation. 50(8). 873–877. 23 indexed citations
8.
Stavenow, Lars, Sölve Elmståhl, Peter Jerntorp, et al.. (1990). Eighty‐year‐old men without cardiovascular disease in the community of Malmö. Part I. Social and medical factors, with special reference to the lipoprotein pattern. Journal of Internal Medicine. 228(1). 9–15. 13 indexed citations
9.
Jerntorp, Peter, et al.. (1988). Clinical utility of serum fructosamine in diabetes mellitus compared with hemoglobin A1c. Clinica Chimica Acta. 175(2). 135–142. 24 indexed citations
10.
Jerntorp, Peter, Jan‐Olof Jeppsson, & G. Sundkvist. (1988). Hemoglobin A1c Self‐recording in the Management of Diabetes Mellitus: A Pilot Study. Acta Medica Scandinavica. 223(4). 359–363.
11.
Jerntorp, Peter. (1987). Low Risk of Coronary Heart Disease in Female Type II Diabetic Subjects with Diabetic Relatives. Acta Medica Scandinavica. 222(4). 319–322. 3 indexed citations
12.
Öhlin, Hans, et al.. (1987). Aldehyde dehydrogenase activity and vascular disease in type II diabetes--a comparison between 2 different assays for activity.. PubMed. 6(2). 91–4. 2 indexed citations
13.
Jerntorp, Peter, et al.. (1986). Effects of chlorpropamide and alcohol on aldehyde dehydrogenase activity and blood acetaldehyde concentration.. PubMed. 3(7). 369–72. 4 indexed citations
14.
Jerntorp, Peter, Hans Öhlin, & Lars‐Olof Almér. (1986). Aldehyde Dehydrogenase Activity and Large Vessel Disease in Diabetes Mellitus: A Preliminary Study. Diabetes. 35(3). 291–294. 8 indexed citations
15.
Jerntorp, Peter, et al.. (1986). Measurement of hemoglobin A1c by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated.. Clinical Chemistry. 32(10). 1867–1872. 230 indexed citations
16.
Jeppsson, Jan‐Olof, et al.. (1986). Measurement of hemoglobin A1c by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated.. PubMed. 32(10). 1867–72. 263 indexed citations
17.
Öhlin, Hans, et al.. (1982). Chlorpropamide-alcohol flushing, aldehyde dehydrogenase activity, and diabetic complications.. BMJ. 285(6345). 838–840. 14 indexed citations
18.
Jerntorp, Peter, et al.. (1982). Chlorpropamide‐alcohol Flushing in Relation to Macroangiopathy and Peripheral Neuropathy in Non‐insulin Dependent Diabetes. Acta Medica Scandinavica. 210(S656). 33–36. 15 indexed citations
19.
Jerntorp, Peter, U. Lennart Hulthén, & Lars‐Olof Almér. (1982). Chlorpropamide‐alcohol Flushing and Blood Kinins. Acta Medica Scandinavica. 210(S656). 37–38. 1 indexed citations
20.
Jerntorp, Peter, Hans Öhlin, B. Bergström, & Lars‐Olof Almér. (1981). Increase of Plasma Acetaldehyde: An Objective Indicator of the Chlorpropamide Alcohol Flush. Diabetes. 30(9). 788–791. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026